GastroEsophageal Cancer clinical trials at UCSF
1 in progress, 1 open to new patients
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
open to eligible people ages 18 years and up
This study evaluates APX005M, in combination with chemoradiation, in patients with resectable cancers of the esophagus and gastroesophageal (GE) junction, including both squamous cell and adenocarcinomas.
San Francisco, California